VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 206 filers reported holding VIR BIOTECHNOLOGY INC in Q1 2022. The put-call ratio across all filers is 0.66 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $470,964 | +36.4% | 50,263 | +257.2% | 0.02% | +38.5% |
| Q2 2023 | $345,162 | -85.2% | 14,071 | -86.0% | 0.01% | -86.6% |
| Q1 2023 | $2,337,541 | +129.2% | 100,453 | +149.3% | 0.10% | +79.6% |
| Q4 2022 | $1,019,765 | +214.7% | 40,291 | +139.8% | 0.05% | +315.4% |
| Q3 2022 | $324,000 | -48.4% | 16,800 | -31.2% | 0.01% | -51.9% |
| Q1 2022 | $628,000 | -64.1% | 24,414 | -33.9% | 0.03% | -84.0% |
| Q2 2021 | $1,747,000 | -8.6% | 36,951 | -0.9% | 0.17% | -5.6% |
| Q1 2021 | $1,912,000 | +146.7% | 37,300 | +28.8% | 0.18% | +35.6% |
| Q4 2020 | $775,000 | – | 28,949 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,559,142 | $30,100,000 | 23.79% |
| SB INVESTMENT ADVISERS (UK) LTD | 22,086,280 | $425,823,000 | 3.26% |
| Zebra Capital Management LLC | 40,104 | $773,000 | 2.94% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 130,409 | $2,514,000 | 0.94% |
| CLARK ESTATES INC/NY | 180,000 | $3,470,000 | 0.77% |
| Temasek Holdings (Private) Ltd | 6,036,821 | $116,389,909 | 0.70% |
| SECTOR GAMMA AS | 89,808 | $1,731,000 | 0.45% |
| Capital Impact Advisors, LLC | 13,196 | $360,000 | 0.36% |
| SummerHaven Investment Management, LLC | 24,927 | $481,000 | 0.33% |
| DUALITY ADVISERS, LP | 92,712 | $1,787,000 | 0.20% |